Quality assurance of chondrocytes
AssigneeXintela AB
InventorsEvy Lundgren Åkerlund, Katarzyna Chmielarska Masoumi
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods that are based on expression of integrin alpha10 and integrin alpha11 on chondrocytes, used for determining purity, quality, degree of chondrocytic identity, chondrocytic potency, and/or degree of chondrocytic phenotype of a composition comprising chondrocytes, as well as for isolating and enriching a population of high quality chondrocytes and controlling culturing and expanding of high quality chondrocytes. The present invention relates also to composition comprising chondrocytes.
Claims15
A composition comprising isolated and cultured chondrocytes, wherein said composition has an integrin alpha10 to integrin alpha11 expression ratio of at least 4 to 1.
Dependencies are inferred from the claim text.